Chemed (CHE) to Release Earnings on Wednesday

Chemed (NYSE:CHE - Get Free Report) will likely be posting its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect Chemed to post earnings of $6.78 per share and revenue of $636.10 million for the quarter. Persons that are interested in registering for the company's earnings conference call can do so using this link.

Chemed Stock Down 1.0 %

Shares of CHE stock traded down $5.35 during trading hours on Friday, hitting $544.75. 126,310 shares of the company were exchanged, compared to its average volume of 89,824. Chemed has a 1 year low of $512.12 and a 1 year high of $654.62. The firm has a fifty day moving average of $542.60 and a 200 day moving average of $563.80. The firm has a market cap of $8.20 billion, a PE ratio of 27.53, a PEG ratio of 2.17 and a beta of 0.48.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date of this dividend is Monday, February 24th. Chemed's dividend payout ratio is currently 10.11%.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares in the company, valued at approximately $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 732 shares of the firm's stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares in the company, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have recently commented on CHE shares. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada dropped their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research note on Tuesday, November 5th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.